Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Net Margin (2016 - 2025)

Historic Net Margin for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Q3 2025 value amounting to 23.5%.

  • Cumberland Pharmaceuticals' Net Margin fell 65900.0% to 23.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.09%, marking a year-over-year increase of 213900.0%. This contributed to the annual value of 17.02% for FY2024, which is 10100.0% down from last year.
  • Cumberland Pharmaceuticals' Net Margin amounted to 23.5% in Q3 2025, which was down 65900.0% from 6.78% recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Net Margin registered a high of 10.66% during Q1 2025, and its lowest value of 67.38% during Q4 2023.
  • Over the past 4 years, Cumberland Pharmaceuticals' median Net Margin value was 6.78% (recorded in 2025), while the average stood at 8.74%.
  • Over the last 5 years, Cumberland Pharmaceuticals' Net Margin had its largest YoY gain of 491600bps in 2024, and its largest YoY loss of -242600bps in 2024.
  • Cumberland Pharmaceuticals' Net Margin (Quarter) stood at 6.05% in 2021, then plummeted by -1214bps to 67.38% in 2023, then skyrocketed by 73bps to 18.22% in 2024, then fell by -29bps to 23.5% in 2025.
  • Its last three reported values are 23.5% in Q3 2025, 6.78% for Q2 2025, and 10.66% during Q1 2025.